Vet Med - Czech, 2009, 54(7):295-314 | DOI: 10.17221/97/2009-VETMED

Residual pharmaceutically active compounds (PhACs) in aquatic environment - status, toxicity and kinetics: a review

Z.H. Li, T. Randak
University of South Bohemia Ceske Budejovice, Research Institute of Fish Culture and Hydrobiology Vodnany, Czech Republic

Awareness of residual pharmaceutically active compounds (PhACs) in aquatic ecosystems is growing as research into these pollutants increases and analytical detection techniques improve. For most pharmaceuticals analyzed, the effects on aquatic organisms have usually been investigated by toxic assays in the laboratory. However, little is known about integral analysis of pharmacokinetics in aquatic organisms and specific relations between pharmacokinetic parameters and influence factors. Moreover, the influence of the organisms involved and numerous other external factors complicates development of standard tests for environmental evaluation. Current knowledge about residual pharmaceuticals in the aquatic environment, including status, toxic effects, and pharmacokinetics in aquatic organisms, are reviewed. Based on the above, we identify major gaps in the current knowledge and some directions for future research, such as improvement of techniques to remove residual pharmaceuticals from wastewater, and the establishment of standard pharmaceutical modes of action.

Keywords: residual PhACs; aquatic environment; status; toxicity; kinetics

Published: July 31, 2009  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Li ZH, Randak T. Residual pharmaceutically active compounds (PhACs) in aquatic environment - status, toxicity and kinetics: a review. Vet Med-Czech. 2009;54(7):295-314. doi: 10.17221/97/2009-VETMED.
Download citation

References

  1. Abedini S., Namdari R., Law F.C.P. (1998): Comparative pharmacokinetics and bioavailability of oxytetracycline in rainbow trout and chinook salmon. Aquaculture, 162, 23-32. Go to original source...
  2. Barron M.G., Gedutis C., James M.O. (1988): Pharmacokinetics of sulfadimethoxine in the Lobster, Homarus americanus, following intrapericardial administration. Xenobiotica, 18, 269-276. Go to original source... Go to PubMed...
  3. Barron M.G., Hansen S.C., Ball T. (1991): Pharmacokinetics and metabolism of triclopyr in the Crayfish (Procambarus clarki). Drug Metabolism and Disposition, 19, 163-167.
  4. Bjorklund H.V., Bylund G. (1991): Comparative pharmacokinetics and bioavailability of oxolinic acid and oxytetracycline in rainbow trout (Oncorhynchus mykiss). Xenobiotica, 21, 1511-1520. Go to original source... Go to PubMed...
  5. Bolis C.L., Piccolella M., Dalla Valle A.Z., Rankin J.C. (2001): Fish as model in pharmacological and biological research. Pharmacological Research, 44, 265-280. Go to original source... Go to PubMed...
  6. Bonga S.E.W. (1997): The stress response in fish. Physiological Reviews, 77, 591-625. Go to original source... Go to PubMed...
  7. Boon J.H., Nouws J.M.F., Vanderheijden M.H.T., Booms G.H.R., Degen M. (1991): Disposition of flumequine in plasma of European eel (Anguilla anguilla) after a single intramuscular injection. Aquaculture, 99, 213-223. Go to original source...
  8. Bound J.P., Voulvoulis N. (2004): Pharmaceuticals in the aquatic environment - a comparison of risk assessment strategies. Chemosphere, 56, 1143-1155. Go to original source... Go to PubMed...
  9. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., La Point T.W. (2003): Aquatic ecotoxicology of fluoxetine. Toxicology Letters, 142, 169-183. Go to original source... Go to PubMed...
  10. Brown S.B., Adams B.A., Cyr D.G., Eales J.G. (2004): Contaminant effects on the teleost fish thyroid. Environmental Toxicology and Chemistry, 23, 1680- 1701. Go to original source... Go to PubMed...
  11. Buser H.R., Muller M.D., Theobald N. (1998): Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environmental Science & Technology, 32, 188-192. Go to original source...
  12. Canton J.H., Vanesch G.J. (1976): Short-term toxicity of some feed additives to different freshwater organisms. Bulletin of Environmental Contamination and Toxicology, 15, 720-725. Go to original source... Go to PubMed...
  13. Chiayvareesajja S., Chandumpai A., Theapparat Y., Faroongsarng D. (2006): The complete analysis of oxytetracycline pharmacokinetics in farmed Pacific white shrimp (Litopenaeus vannamei). Journal of Veterinary Pharmacology and Therapeutics, 29, 409-414. Go to original source... Go to PubMed...
  14. Cleuvers M. (2003): Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicology Letters, 142, 185-194. Go to original source... Go to PubMed...
  15. Crane M., Watts C., Boucard T. (2006): Chronic aquatic environmental risks from exposure to human pharmaceuticals. Science of the Total Environment, 367, 23-41. Go to original source... Go to PubMed...
  16. Curtis L.R., Kemp C.J., Svec A.V. (1986): Biliary-excretion of [C-14] taurocholate by rainbow trout (Salmo gairdneri) is stimulated at warmer acclimation temperature. Comparative Biochemistry and Physiology C-Pharmacology Toxicology & Endocrinology, 84, 87-90. Go to original source... Go to PubMed...
  17. Daughton C.G., Ternes T.A. (1999): Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107, 907-938. Go to original source... Go to PubMed...
  18. Desbrow C., Routledge E.J., Brighty G.C., Sumpter J.P., Waldock M. (1998): Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environmental Science and Technology, 32, 1549-1558. Go to original source...
  19. Drewes J.E., Heberer T., Reddersen K. (2002): Fate of pharmaceuticals during indirect potable reuse. Water Science and Technology, 46, 73-80. Go to original source...
  20. Eckel W.P., Ross B., Isensee R.K. (1993): Pentobarbital found in-ground water. Ground Water, 31, 801-804. Go to original source...
  21. Emblidge J.P., DeLorenzo M.E. (2006): Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species. Environmental Research, 100, 216-226. Go to original source... Go to PubMed...
  22. Fang W.H., Hu L.L., Yang X.L., Hu K., Liang S.C., Zhou S. (2008): Effect of temperature on pharmacokinetics of enrofloxacin in mud crab, Scylla serrata (Forsskal), following oral administration. Journal of Fish Diseases, 31, 171-176. Go to original source... Go to PubMed...
  23. Faroongsamg D., Chandumpai A., Chiayvareesajja S., Theapparat Y. (2007): Bloavailability and absorption analysis of oxytetracycline orally administered to the standardized moulting farmed Pacific white shrimps (Penaeus vannamei). Aquaculture, 269, 89-97. Go to original source...
  24. Fent K., Weston A.A., Caminada D. (2006): Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76, 122-159. Go to original source... Go to PubMed...
  25. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., Garric J. (2003): Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicology and Environmental Safety, 55, 359-370. Go to original source... Go to PubMed...
  26. Ferreira C.S.G., Nunes B.A., de Melo Henriques-Almeida J.M., Guilhermino U. (2007): Acute toxicity of oxytetracycline and florfenicol to the microalgae Tetraselmis chuii and to the crustacean Artemia parthenogenetica. Ecotoxicology and Environmental Safety, 67, 452-458. Go to original source... Go to PubMed...
  27. Golet E.M., Alder A.C., Giger W. (2002): Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley Watershed, Switzerland. Environmental Science and Technology, 36, 3645-3651. Go to original source... Go to PubMed...
  28. Gore S. R., Harms C.A., Kukanich B., Forsythe J., Lewbart G.A., Papich M.G. (2005): Enrofloxacin pharmacokinetics in the European cuttlefish, Sepia officinalis, after a single i.v. injection and bath administration. Journal of Veterinary Pharmacology and Therapeutics, 28, 433-439. Go to original source... Go to PubMed...
  29. Guenette S.A., Uhland F.C., Helie P., Beaudry F., Vachon P. (2007): Pharmacokinetics of eugenol in rainbow trout (Oncorhynchus mykiss). Aquaculture, 266, 262-265. Go to original source...
  30. Halley B.A., Jacob T.A., Lu A.Y.H. (1989): The environmental impact of the use of ivermectin - environmental-effects and fate. Chemosphere, 18, 1543-1563. Go to original source...
  31. Hansen M. K., Horsberg T.E. (1999): Single-dose pharmacokinetics of flumequine in halibut (Hippoglossus hippoglossus) and turbot (Scophthalmus maximus). Journal of Veterinary Pharmacology and Therapeutics, 22, 122-126. Go to original source... Go to PubMed...
  32. Hansen M.K., Horsberg T.E. (2000a): Single-dose pharmacokinetics of flumequine in cod (Gadus morhua) and goldsinny wrasse (Ctenolabrus rupestris). Journal of Veterinary Pharmacology and Therapeutics, 23, 163-168. Go to original source... Go to PubMed...
  33. Hansen M.K., Horsberg T.E. (2000b): Single-dose pharmacokinetics of flumequine in the eel (Anguilla anguilla) after intravascular, oral and bath administration. Journal of Veterinary Pharmacology and Therapeutics, 23, 169-174. Go to original source... Go to PubMed...
  34. Hansen M.K., Nymoen U., Horsberg T.E. (2003): Pharmacokinetic and pharmacodynamic properties of metomidate in turbot (Scophthalmus maximus) and halibut (Hippoglossus hippoglossus). Journal of Veterinary Pharmacology and Therapeutics, 26, 95-103. Go to original source... Go to PubMed...
  35. Haug T., Hals P.A. (2000): Pharmacokinetics of oxytetracyline in Arctic charr (Salvelinus alpinus L.) in freshwater at low temperature. Aquaculture, 186, 175-191. Go to original source...
  36. Hazel J.R. (1984): Effects of temperature on the structure and metabolism of cell-membranes in fish. American Journal of Physiology, 246, R460-R470. Go to original source... Go to PubMed...
  37. Heberer T. (2002): Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letters, 131, 5-17. Go to original source... Go to PubMed...
  38. Henry T.B., Black M.C. (2008): Acute and chronic toxicity of fluoxetine (selective serotonin reuptake inhibitor) in western mosquitofish. Archives of Environmental Contamination and Toxicology, 54, 325-330. Go to original source... Go to PubMed...
  39. Ho S.P., Cheng C.F., Wang W.S. (1999): Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla). Journal of Veterinary Medical Science, 61, 459-463. Go to original source... Go to PubMed...
  40. Holm J.V., Bjerg P.L., Rugge K., Christensen T.H. (1995): Occurrence and distribution of pharmaceutical organic-compounds in the groundwater downgradient of a landfill (Grindsted, Denmark) - response. Environmental Science and Technology, 29, 3074-3074. Go to original source... Go to PubMed...
  41. Horsberg T.E., Martinsen B., Sandersen K., Zernichow L. (1997): Potentiated sulfonamides: In vitro inhibitory effect and pharmacokinetic properties in Atlantic salmon in seawater. Journal of Aquatic Animal Health, 9, 203-210. Go to original source...
  42. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., Schlenk D. (2002): Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Archives of Environmental Contamination and Toxicology, 43, 229-235. Go to original source... Go to PubMed...
  43. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. (2003): A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Human and Ecological Risk Assessment, 9, 1789-1799. Go to original source...
  44. Hustvedt S.O., Salte R. (1991): Distribution and elimination of oxolinic acid in rainbow trout (Oncorhynchus mykiss Walbaum) after a single rapid intravascular injection. Aquaculture, 92, 297-303. Go to original source...
  45. Hutchinson T.., Pounds N.A., Hampel M., Williams T. D. (1999): Life-cycle studies with marine copepods (Tisbe battagliai) exposed to 20-hydroxyecdysone and diethylstilbestrol. Environmental Toxicology and Chemistry, 18, 2914-2920. Go to original source...
  46. Hutchinson T.H., Yokota H., Hagino S., Ozato K. (2003): Development of fish tests for endocrine disruptors. Pure and Applied Chemistry, 75, 2343-2353. Go to original source...
  47. Intorre L., Cecchini S., Bertini S., Varriale A.M.C., Soldani G., Mengozzi G. (2000): Pharmacokinetics of enrofloxacin in the seabass (Dicentrarchus labrax). Aquaculture, 182, 49-59. Go to original source...
  48. Isidori M., Lavorgna M., Nardelli A., Pascarella L., Parrella A. (2005): Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Science of the Total Environment, 346, 87-98. Go to original source... Go to PubMed...
  49. Jjemba P.K. (2006): Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicology and Environmental Safety, 63, 113-130. Go to original source... Go to PubMed...
  50. Jorgensen S.E., Halling-Sorensen B. (2000): Drugs in the environment. Chemosphere, 40, 691-699. Go to original source... Go to PubMed...
  51. Kim Y., Choi K., Jung J.Y., Park S., Kim P.G., Park J. (2007): Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environment International, 33, 370-375. Go to original source... Go to PubMed...
  52. Kleinow K.M., Jarboe H.H., Shoemaker K.E., Greenless K.J. (1994): Comparative pharmacokinetics and bioavailability of oxolinic acid in channel catfish (Ictalurus punctatus) and rainbow trout (Oncorhynchus mykiss). Canadian Journal of Fisheries and Aquatic Sciences, 51, 1205-1211. Go to original source...
  53. Kummerer K. (2004): Pharmaceuticals in the Environment. 2nd ed. Springer-Verlag, City, Pages?
  54. Macri A., Sbardella E. (1984): Toxicological evaluation of nitrofurazone and furaltadone on selenastrum-capricornutum, Daphnia magna, and Muscad omestica. Ecotoxicology and Environmental Safety, 8, 101-105. Go to original source... Go to PubMed...
  55. Maltby J.B., Albright L.J., Kennedy C.J., Higgs D.A. (2003): Effect of route of administration and carrier on bioavailability and kinetics of astaxanthin in Atlantic salmon Salmo salar L. Aquaculture Research, 34, 829-838. Go to original source...
  56. Martinsen B., Horsberg T.E. (1995): Comparative singledose pharmacokinetics of 4 quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic Salmon (Salmo salar) held in seawater at 10-degrees-C. Antimicrobial Agents and Chemotherapy, 39, 1059- 1064. Go to original source... Go to PubMed...
  57. Martinsen B., Horsberg T.E., Varma K.J., Sams R. (1993): Single-dose pharmacokinetic study of florfenicol in Atlantic salmon (Salmo salar) in seawater at 11-degrees-C. Aquaculture, 112, 1-11. Go to original source...
  58. Migliore L., Civitareale C., Brambilla G., DiDelupis G. D. (1997): Toxicity of several important agricultural antibiotics to Artemia. Water Research, 31, 1801-1806. Go to original source...
  59. Minagh E., Hernan R., O'Rourke K., Lyng F.M., Davoren M. (2009): Aquatic ecotoxicity of the selective serotonin reuptake inhibitor sertraline hydrochloride in a battery of freshwater test species. Ecotoxicology and Environmental Safety, 72, 434-440. Go to original source... Go to PubMed...
  60. Nakamura Y., Yamamoto H., Sekizawa J., Kondo T., Hirai N., Tatarazako N. (2008): The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): Acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere, 70, 865-873. Go to original source... Go to PubMed...
  61. Newby N.C., Mendonca P.C., Gamperl K., Stevens E.D. (2006): Pharmacokinetics of morphine in fish: Winter flounder (Pseudopleuronectes americanus) and seawater-acclimated rainbow trout (Oncorhynchus mykiss). Comparative Biochemistry and Physiology C-Toxicology and Pharmacology, 143, 275-283. Go to original source... Go to PubMed...
  62. Nie X.P., Wang X., Chen J., Zitko V., An T. (2008): Response of the freshwater alga Chlorella vulgaris to trichloroisocyanuric acid and ciprofloxacin. Environmental Toxicology and Chemistry, 27, 168-173. Go to original source... Go to PubMed...
  63. Nolan M.W., Smith S.A., Jones D. (2007): Pharmacokinetics of oxytetracycline in the American horseshoe crab, Limulus polyphemus. Journal of Veterinary Pharmacology and Therapeutics, 30, 451-455. Go to original source... Go to PubMed...
  64. Nunes B., Carvalho F., Guilhermino L. (2004): Acute and chronic effects of clofibrate and clofibric acid on the enzymes acetylcholinesterase, lactate dehydrogenase and catalase of the mosquitofish, Gambusia holbrooki. Chemosphere, 57, 1581-1589. Go to original source... Go to PubMed...
  65. Nunes B., Carvalho F., Guilhermino L. (2005): Acute toxicity of widely used pharmaceuticals in aquatic species: Gambusia holbrooki, Artemia parthenogenetica and Tetraselmis chuii. Ecotoxicology and Environmental Safety, 61, 413-419. Go to original source... Go to PubMed...
  66. Oie S., Tozer T.N. (1979): Effect of altered plasma-protein binding on apparent volume of distribution. Journal of Pharmaceutical Sciences, 68, 1203-1205. Go to original source... Go to PubMed...
  67. Park E.D., Lightner D.V., Stamm J.M., Bell T.A. (1994): Preliminary studies on the palatability, animal safety, and tissue residues of sarafloxacin-HCl in the Penaeid shrimp, Penaeus vannamei. Aquaculture, 126, 231-241. Go to original source...
  68. Park E.D., Lightner D.V., Milner N., Mayersohn M., Park D.L., Gifford J.M., Bell T.A. (1995): Exploratory bioavailability and pharmacokinetic studies of sulfadimethoxine and ormetoprim in the Penaeid shrimp, Penaeus vannamei. Aquaculture, 130, 113-128. Go to original source...
  69. Plakas S.M., Dickey R.W., Barron M.G., Guarino A.M. (1990): Tissue distribution and renal excretion of ormetoprim after intravascular and oral-administration in the channel catfish (Ictalurus punctatus). Canadian Journal of Fisheries and Aquatic Sciences, 47, 766-771. Go to original source...
  70. Plakas S.M., El Said K.R., Musser S.M. (2000): Pharmacokinetics, tissue distribution, and metabolism of flumequine in channel catfish (Ictalurus punctatus). Aquaculture, 187, 1-14. Go to original source...
  71. Poher I., Blanc G., Loussouarn S. (1997): Pharmacokinetics of oxolinic acid in sea-bass, Dicentrarchus labrax (L. 1758), after a single rapid intravascular injection. Journal of Veterinary Pharmacology and Therapeutics, 20, 267-275. Go to original source... Go to PubMed...
  72. Reed L.A., Siewicki T.C., Shah J. C. (2004): Pharmacokinetics of oxytetracycline in the white shrimp, Litopenaeus setiferus. Aquaculture, 232, 11-28. Go to original source...
  73. Reddersen K., Heberer T., Dunnbier U. (2002): Identification and significance of phenazone drugs and their metabolites in ground- and drinking water. Chemosphere, 49, 539-544. Go to original source... Go to PubMed...
  74. Rigos G., Alexis M., Tyrpenou A.E., Nengas I., Piper I., Troisi G. (2002a): Pharmacokinetics of oxolinic acid in gilthead sea bream, Sparus aurata L. Journal of Fish Diseases, 25, 401-408. Go to original source...
  75. Rigos G., Tyrpenou A., Nengas I., Alexis M. (2002b): A pharmacokinetic study of flumequine in sea bass, Dicentrarchus labrax (L.), after a single intravascular injection. Journal of Fish Diseases, 25, 101-105. Go to original source...
  76. Rigos G., Nengas I., Tyrpenou A.E., Alexis M., Troisi G.A. (2003): Pharmacokinetics and bioavailability of oxytetracycline in gilthead sea bream (Sparus aurata) after a single dose. Aquaculture, 221, 75-83. Go to original source...
  77. Rogstad A., Ellingsen O.F., Syvertsen C. (1993): Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture, 110, 207-220. Go to original source...
  78. Saha S., Kaviraj A. (2008): Acute toxicity of synthetic pyrethroid cypermethrin to some freshwater organisms. Bulletin of Environmental Contamination and Toxicology, 80, 49-52. Go to original source... Go to PubMed...
  79. Samuelsen O.B. (2006): Pharmacokinetics of quinolones in fish: A review. Aquaculture, 255, 55-75. Go to original source...
  80. Samuelsen O.B., Ervik A. (1999): A single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic halibut, Hippoglossus hippoglossus L., held in sea water at 9 degrees C. Journal of Fish Diseases, 22, 13-23. Go to original source...
  81. Samuelsen O.B., Ervik A., Pursell L., Smith P. (2000): Single-dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in Atlantic salmon (Salmo salar) held in seawater and in vitro antibacterial activity against Aeromonas salmonicida. Aquaculture, 187, 213-224. Go to original source...
  82. Samuelsen O.B., Bergh O., Ervik A. (2003a): Pharmacokinetics of florfenicol in cod Gadus morhua and in vitro antibacterial activity against Vibrio anguillarum. Diseases of Aquatic Organisms, 56, 127-133. Go to original source... Go to PubMed...
  83. Samuelsen O.B., Bergh O., Ervik A. (2003b): A singledose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, in cod, Gadus morhua L., held in sea water at 8 degrees C and in vitro antibacterial activity of oxolinic acid against Vibrio anguillarum strains isolated from diseased cod. Journal of Fish Diseases, 26, 339-347. Go to original source... Go to PubMed...
  84. Sangrungruang K., Chotchuang A., Ueno R. (2004): Comparative pharmacokinetics and bioavailability of oxytetracycline in giant tiger prawn. Fisheries Science, 70, 467-472. Go to original source...
  85. Santos J.L., Aparicio I., Alonso E. (2007): Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environment International, 33, 596-601. Go to original source... Go to PubMed...
  86. Sohlberg S., Martinsen B., Horsberg T.E., Soli N.E. (1996): Evaluation of the dorsal aorta cannulation technique for pharmacokinetic studies in Atlantic salmon (Salmo salar) in sea water. Journal of Veterinary Pharmacology and Therapeutics, 19, 460-465. Go to original source... Go to PubMed...
  87. Stoffregen D.A., Wooster G.., Bustos P.S., Bowser P.R., Babish J.G. (1997): Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon. Journal of Veterinary Pharmacology and Therapeutics, 20, 111-123. Go to original source... Go to PubMed...
  88. Sumpter J.P. (2008): The ecotoxicology of hormonally active micropollutants. Water Science and Technology, 57, 125-130. Go to original source... Go to PubMed...
  89. Ternes, T. A. (1998): Occurrence of drugs in German sewage treatment plants and rivers. Water Research, 32, 3245-3260. Go to original source...
  90. Ternes T.A., Joss A., Siegrist H. (2004): Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology, 38, 392a-399a. Go to original source... Go to PubMed...
  91. Thorpe K.L., Cummings R.I., Hutchinson T.H., Scholze M., Brighty G., Sumpter J.P., Tyler C. R. (2003): Relative potencies and combination effects of steroidal estrogens in fish. Environmental Science and Technology 37, 1142-1149. Go to original source... Go to PubMed...
  92. Ueno R., Kinoshita A., Wakabayashi, J. (2004): Comparative pharmacokinetics of oxytetracycline in eel and its fate in a closed aquatic environment. Aquaculture, 235, 53-63. Go to original source...
  93. Uno K. (1996): Pharmacokinetic study of oxytetracycline in healthy and vibriosis-infected ayu (Plecoglossus altivelis). Aquaculture, 143, 33-42. Go to original source...
  94. Uno K. (2004): Pharmacokinetics of oxolinic acid and oxytetracycline in kuruma shrimp, Penaeus japonicus. Aquaculture, 230, 1-11. Go to original source...
  95. Uno K., Aoki T., Ueno R., Maeda I. (1997): Pharmacokinetics of oxytetracycline in rainbow trout Oncorhynchus mykiss following bolus intravenous administration. Fisheries Science, 63, 90-93. Go to original source...
  96. Uno K., Aoki, T., Kleechaya W., Tanasomwang V., Ruangpan L. (2006): Pharmacokinetics of oxytetracycline in black tiger shrimp, Penaeus monodon, and the effect of cooking on the residues. Aquaculture, 254, 24-31. Go to original source...
  97. Urase T., Kikuta T. (2005): Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Research, 39, 1289-1300. Go to original source... Go to PubMed...
  98. Vick A. M., Hayton W.L. (2001): Methyltestosterone pharmacolinetics and oral bioavailability in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology, 52, 177-188. Go to original source... Go to PubMed...
  99. Vieno N., Tuhkanen T., Kronberg L. (2007): Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Research, 41, 1001-1012. Go to original source... Go to PubMed...
  100. Vos J. G., Dybing E., Greim H.A., Ladefoged O., Lambre C., Tarazona J.V., Brandt I., Vethaak A.D. (2000): Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation. Critical Reviews in Toxicology, 30, 71-133. Go to original source... Go to PubMed...
  101. Wilga J., Kot-Wasik A., Namiesnik J. (2008): Studies of human and veterinary drugs' fate in environmental solid samples - analytical problems. Journal of Chromatographic Science, 46, 601-608. Go to original source... Go to PubMed...
  102. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramil M., Ternes T. A., Giltrow E., Sumpter J.P., Hutchinson T.H. (2008): Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquatic Toxicology, 86, 361-369. Go to original source... Go to PubMed...
  103. Wollenberger L., Halling-Sorensen B., Kusk K.O. (2000): Acute and chronic toxicity of veterinary antibiotics to Daphnia magna. Chemosphere, 40, 723-730. Go to original source... Go to PubMed...
  104. Yanong R.P.E., Curtis E.W., Simmons R., Bhattaram V.A., Gopalakrishnan M., Ketabi N., Nagaraja N.V., Derendorf H. (2005): Pharmacokinetic studies of florfenicol in koi carp and threespot gourami Trichogaster trichopterus after oral and intramuscular treatment. Journal of Aquatic Animal Health, 17, 129-137. Go to original source...
  105. Zhang Q.Z., Li X.M. (2007): Pharmacokinetics and residue elimination of oxytetracycline in grass carp, Ctenopharyngodon idellus. Aquaculture, 272, 140-145. Go to original source...
  106. Zwiener C., Frimmel F.H. (2000): Oxidative treatment of pharmaceuticals in water. Water Research, 34, 1881- 1885. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.